Bellevue Life Sciences Acquisition (BLAC) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Bellevue Life Sciences Acquisition Corp  (NASDAQ: BLAC)
 

Bellevue Life Sciences Acquisition Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Bellevue Life Sciences Acquisition's inventory turnover ratio sequentially decreased to 3.26 in the second quarter 2026, unsurprisingly, as the Bellevue Life Sciences Acquisition markets continue to deteriorate, and BLAC's faces growing challenges to bring down its inventories. Bellevue Life Sciences Acquisition's average inventory processing period in the Jun 30 2026 quarter, has increased to 112 days, from 49 days, in the Mar 31 2026 quarter.

Within Healthcare sector 110 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 507, from total ranking in the first quarter 2026 at 560.

BLAC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bellevue Life Sciences Acquisition Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLAC Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 198.9 % -37.22 % - - -
Y / Y Cost of Sales Growth -77.09 % -45.36 % - -43.16 % 53.96 %
Inventory Turnover Ratio (TTM) 3.26 7.45 6.71 6.99 9.56
BLAC's Total Ranking # 507 # 560 # 0 # 0 #
Average inventory processing period 112 49 54 52 38
Seq. Inventory Growth 28.51 % 135.47 % 6.11 % -6.91 % -73.01 %
Seq. Cost of Sales Growth -29.25 % 28.69 % -31.26 % -63.4 % 68.75 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 45
Healthcare Sector # 111
Overall Market # 507

Inventory Turnover Ratio Statistics
High Average Low
7.62 5.95 3.38
(Mar 31 2026)   (Jun 30 2026)



BLAC Company Profile >> Back to BLAC Efficiency Comparisons >> Compare BLAC Inventory Turnover Ratio to its Competitors

Financial Statements
Bellevue Life Sciences Acquisition's Inventories $ 1 Millions Visit BLAC's Balance sheet
Bellevue Life Sciences Acquisition's Cost of Revenues TTM $ 1 Millions Visit BLAC's Income Statement
What are BLAC's Sales? Visit BLAC's Sales by Segment

Other Inventory Turnover Ratios
Bellevue Life Sciences Acquisition's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BLAC's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BLAC's Competitors
Inventory Turnover Ratio for BLAC's Suppliers
Inventory Turnover Ratio for BLAC's Customers

You may also want to know
BLAC's Sales Growth Rates BLAC's Pe Price to earnings ratio BLAC's Receivables Turnover Ratio BLAC's Stock Quote
BLAC's Net Income Growth Rates BLAC's Ps Price to Sales ratio BLAC's Sales per Employee BLAC's Asset Turnover Ratio
BLAC's Net Margin BLAC's Pb Price to Book ratio BLAC's Financial Strength Ratios BLAC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Agilent Technologies inc   3.17 $ 3,404.000  Millions$ 1,073  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions

Date modified: 2026-08-17T17:21:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.